Beta-blocker use and mortality among patients with systolic heart failure and pacemaker rhythm.

Beta-blocker therapy is associated with improved survival among patients with heart failure and a pacemaker rhythm on ECG. Further studies are necessary to analyse differences between atrial and ventricular pacemakers.